Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
51.20    0.30 (0.59%)
Bid:
50.80
Ask:
51.30
Spread: 0.50 (0.984%)
Market Cap: £324.03m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

Director/PDMR Shareholding

28 Nov 2025 12:30

RNS Number : 4869J
Marston's PLC
28 November 2025
Β 

28 November 2025

Β 

Notification of interests of directors and persons discharging managerial responsibilities

Marston's PLC (the "Company") announces that on 27 November 2025 the Directors listed below were granted awards over ordinary shares in the Company under the Company's Long Term Incentive Plan (the "Plan").

Β 

The number of shares over which awards were granted was calculated using the market price at the close of trading on the London Stock Exchange on 27 November 2025, being Β£0.597 per ordinary share.

Β 

Awards under the Plan may comprise two elements:

Β 

(i) a nil-cost option (a "Nil-Cost Option"), and

Β 

(ii) a CSOP Option over shares with a total value at the date of grant of Β£60,000 (the statutory limit) with an exercise price of Β£0.597 per share (a "CSOP Option").

Β 

The awards will ordinarily vest on the third anniversary of the date of grant to the extent the performance metrics are satisfied. The performance metrics are based on Underlying Profit Before Tax (as regards 40% of the award), Operating Margin (as regards 30% of the award) and Relative Total Shareholder Return (as regards 30% of the award) assessed over the Company's 2026, 2027 and 2028 financial periods, details of which will be set out in the Company's Annual Report and Accounts for the period ended 27Β SeptemberΒ 2025.

Β 

To the extent the performance metrics are met, a Nil-Cost Option will be released following a two-year holding period.

Β 

Linking Arrangement between Nil-Cost Option and CSOP Option

The options granted to Stephen Hopson have been granted such that the maximum pre-tax value delivered to him will not exceed the value of the shares over which the Nil-Cost Option would have vested if it was a standalone option.

Β 

The CSOP option will be released only to the extent that the aggregate CSOP gain is less than or equal to the value of the shares over which the Nil-Cost Option would be released on the normal released date.

Β 

Name of individual

Designation

Number of shares subject to CSOP Option

Number of shares subject to Nil-Cost Option

Justin Platt

Director

N/A

1,590,452

Stephen Hopson

Director

100,502

785,175

Β 

The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.

Β 

Β 

Enquiries:

Bethan Raybould, General Counsel & Company Secretary, Marston's PLC, +44 (0) 1902 907250

Β 

Β 

Β 

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")

a)

Name

Stephen Hopson

Β 

2.

Reason for the notification

a)

Position/status

Director and PDMR (Chief Financial Officer)

Β 

b)

Initial notification/

amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Marston's PLC

b)

LEI code

213800Q6RP3ZJ2CZR962

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Β 

Identification code

Ordinary Shares of 7.375 pence each

Β 

Β 

ISIN: GB00B1JQDM80

b)

Nature of the transaction

Grant of award under the Marston's PLC Long Term Incentive Plan in the form of a CSOP option with an exercise price of Β£0.597 per share and a nil-cost option.

c)

Price(s) and volumes(s)

Β 

Price

Volume

Nil-cost option: N/A

785,175

CSOP option: Β£0.597

100,502

d)

Aggregated information

- Aggregate volume

Β 

- Price

Β 

Β 

N/A

Β 

e)

Date of the transaction

2025-11-27

f)

Place of the transaction

Outside a trading venue

Β 

Β 

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")

a)

Name

Justin Platt

Β 

2.

Reason for the notification

a)

Position/status

Director and PDMR (Chief Executive Officer)

Β 

b)

Initial notification/ amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Marston's PLC

b)

LEI code

213800Q6RP3ZJ2CZR962

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Β 

Identification code

Ordinary Shares of 7.375 pence each

Β 

Β 

ISIN: GB00B1JQDM80

b)

Nature of the transaction

Grant of award under the Marston's PLC Long Term Incentive Plan in the form of a nil-cost option.

Β 

c)

Price(s) and volumes(s)

Β 

Price

Volume

Nil-cost option: N/A

1,590,452

d)

Aggregated information

- Aggregate volume

Β 

- Price

Β 

Β 

N/A

Β 

e)

Date of the transaction

2025-11-27

f)

Place of the transaction

Outside a trading venue

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHEAAFPAAPSFFA
Date   Source Headline
2nd Feb 20211:02 pmRNSForm 8.3 - Marston's PLC
2nd Feb 202112:00 pmRNSForm 8.5 (EPT/RI) Martson's Plc
2nd Feb 202111:17 amRNSForm 8.5 (EPT/RI)- Marston’s plc
2nd Feb 202111:16 amRNSForm 8.5 (EPT/RI) - Marston’s plc
2nd Feb 202111:03 amBUSFORM 8.3 - MARSTON'S PLC
1st Feb 20214:13 pmRNSForm 8.3 - Marstons Plc
1st Feb 20214:12 pmPRNForm 8.3 - Marston's plc OPD
1st Feb 20213:42 pmEQSForm 8.3 - The Vanguard Group, Inc.: Marston's plc
1st Feb 20213:29 pmRNSUpdate on Possible Offer
1st Feb 20213:28 pmRNSForm 8.3 - Marston's plc
1st Feb 20213:20 pmRNSForm 8.3 - Marston's PLC
1st Feb 20213:00 pmBUSForm 8.3 - MARS LN
1st Feb 20212:58 pmRNSForm 8.3 - Marston's Plc
1st Feb 20212:44 pmPRNForm 8.3 - Marston’s plc
1st Feb 20212:23 pmRNSForm 8.3 - Marston's plc
1st Feb 20212:01 pmBUSForm 8.3 - MARSTON'S PLC
1st Feb 202112:32 pmGNWDimensional Fund Advisors Ltd. : Form 8.3 - MARSTON'S PLC - Ordinary Shares
1st Feb 202112:12 pmRNSRule 2.9 Announcement
1st Feb 202112:00 pmRNSForm 8.5 (EPT/RI) Martson's Plc
1st Feb 202111:47 amRNSForm 8.5 (EPT/RI)- Marston’s plc
1st Feb 202111:41 amRNSForm 8.3 - Marston's plc
1st Feb 202111:34 amRNSForm 8.3 - Marston's PLC
1st Feb 20217:00 amRNSRule 2.9 Announcement
29th Jan 20215:56 pmRNSForm 8.3 - [Marston's PLC]
29th Jan 20214:59 pmRNSRule 2.9 Announcement
29th Jan 202112:25 pmRNSForm 8.3 - Marston's PLC
29th Jan 202111:24 amRNSStatement regarding press speculation
27th Jan 202110:21 amRNSResult of AGM
12th Jan 20218:25 amRNSBlock listing Interim Review
8th Jan 20217:00 amRNSQ1 Update
24th Dec 202012:07 pmRNSAnnual Financial Report
23rd Dec 20207:00 amRNSMarston’s PLC to operate SA Brain pub estate
10th Dec 20207:00 amRNSRESULTS FOR THE 53 WEEKS ENDED 3 OCTOBER 2020
3rd Dec 202010:34 amRNSCOVID-19 Update: Result Noteholder Consent Request
11th Nov 20208:10 amRNSCOVID-19 Update re: Noteholder Consent Request
30th Oct 20202:41 pmRNSCompletion of brewing JV with Carlsberg UK
15th Oct 20207:00 amRNSYear End Trading Update
13th Oct 202011:14 amRNSNotice of Trading Update Announcement Revised Date
9th Oct 20207:09 amRNSCMA CLEARANCE OF JOINT VENTURE WITH CARLSBERG
1st Oct 20207:00 amRNSNotification of Trading Update Announcement Date
22nd Sep 202012:46 pmRNSHolding(s) in Company
7th Aug 20208:00 amRNSAppointment of Joint Corporate Broker
23rd Jul 202012:00 pmRNSTransaction Update
10th Jul 20209:03 amRNSBlock listing Interim Review
2nd Jul 20207:00 amRNSDirector/PDMR Shareholding
29th Jun 20202:30 pmRNSDirector/PDMR Shareholding
29th Jun 20201:36 pmRNSDirector Declaration
29th Jun 20209:27 amRNSDirector/PDMR Shareholding
26th Jun 20207:00 amRNSInterim Results
25th Jun 20209:23 amRNSResult of Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.